Hyperglycemia-Induced Reactive Oxygen Species Toxicity to Endothelial Cells Is Dependent on Paracrine Mediators
Open accessAbstract
OBJECTIVE—This study determined the effects of high glucose exposure and cytokine treatment on generation of reactive oxygen species (ROS) and activation of inflammatory and apoptotic pathways in human retinal endothelial cells (HRECs). RESEARCH DESIGN AND METHODS—Glucose consumption of HRECs, human retinal pigment epithelial cells (HRPEs), and human Müller cells (HMCs) under elevated glucose conditions was measured and compared with cytokine treatment. Production of ROS in HRECs was examined using 5-(and-6)-chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate (CM-H2DCFDA), spin-trap electron paramagnetic resonance, and MitoTracker Red staining after high glucose and cytokine treatment. The activation of different signaling cascades, including the mitogen-activated protein kinase pathways, tyrosine phosphorylation pathways, and apoptosis by high glucose and cytokines in HRECs, was determined. RESULTS—HRECs, in contrast to HRPEs and HMCs, did not increase glucose consumption in response to increasing glucose concentrations. Exposure of HRECs to 25 mmol/l glucose did not stimulate endogenous ROS production, activation of nuclear factor-κB (NF-κB), extracellular signal–related kinase (ERK), p38 and Jun NH2-terminal kinase (JNK), tyrosine phosphorylation, interleukin (IL)-1β, or tumor necrosis factor-α (TNF-α) production and only slightly affected apoptotic cell death pathways compared with normal glucose (5 mmol/l). In marked contrast, exposure of HRECs to proinflammatory cytokines IL-1β or TNF-α increased glucose consumption, mitochondrial superoxide production, ERK and JNK phosphorylation, tyrosine phosphorylation, NF-κB activation, and caspase activation. CONCLUSIONS—Our in vitro results indicate that HRECs respond to cytokines rather than high glucose, suggesting that in vivo diabetes–related endothelial injury in the retina may be due to glucose-induced cytokine release by other retinal cells and not a direct effect of high glucose.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In human retinal endothelial cells, 25 mM glucose does not increase ROS production.
“In contrast, Busik et al. (43) showed that 25 mM glucose did not increase ROS production in human retinal endothelial cells.”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 49 · Cited by 312
- Authors
- Busik, J. V., Mohr, S., & Grant, M. B.
- Affiliations
- Michigan State University (US)
- Case Western Reserve University (US)
- University of Florida (US)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2008-07-01
- Volume
- 57
- Issue
- 7
- Pages
- 1952-1965
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2453610
- OpenAlex
- W2151943707
- Cited by
- 312
- References
- 49
- Citations by year
- 2026: 10 · 2025: 10 · 2024: 10 · 2023: 12 · 2022: 13 · 2021: 18 · 2020: 28 · 2019: 15 · 2018: 24 · 2017: 28 · 2016: 19 · 2015: 16 · 2014: 18 · 2013: 15 · 2012: 20
- FWCI
- 18.90
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health (EY007739)
- National Eye Institute (R01EY017206, EY007739, EY016077, EY-012601, R03EY014380, R01EY007739, EY-014380, EY-017206, R01EY016077, R01EY012601)
- National Institute of Diabetes and Digestive and Kidney Diseases (R21DK065014, DK065014)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
- Keywords
- hyperglycemia, reactive oxygen species, retinal endothelial cells, cytokines, IL-1β, TNF-α, NF-κB, ERK, JNK, mitochondrial superoxide, apoptosis, caspase activation, glucose utilization, paracrine signaling, diabetic retinopathy, Müller cells, retinal pigment epithelium
- MeSH terms
- Diabetic Retinopathy, Glucose, Humans, Hyperglycemia, Mitochondria, Pigment Epithelium of Eye, Superoxides, Cytokines, Annexin A5, Reactive Oxygen Species, Oxidative Stress, Cell Culture Techniques, Vascular Cell Adhesion Molecule-1, Caspases, Electromagnetic Phenomena
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review